New hope for Tough-to-Treat blood cancer
NCT ID NCT06105554
Summary
This early-stage study is testing a new drug called belumosudil for people with multiple myeloma, a blood cancer, that has come back or stopped responding to standard treatments. The first part aims to find a safe dose. The second part will see if that dose, given alone or with a steroid (dexamethasone), can help control the disease. It is for adults who have already tried at least three other types of therapy.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.